Download TOC as PDF
5 Volumes:
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 1
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 2
COVID-19 Pandemic Mitigation products Market – 2020-2024: Volume 3
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 4
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 5
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 1
Download the PDF
1 Market Definition………………………………….. 9
1.1 Introduction…………………………………….. 9
1.2 Scenario A: Assumptions………………….. 9
1.3 Scenario B: Assumptions………………….. 9
2 Executive Summary…………………………….. 11
2.1 Key Findings…………………………………. 11
2.2 COVID-19 Mitigation Funding (January – May 2020)……………………………………. 27
2.3 Key Conclusions……………………………. 30
2.4 COVID-19 Pandemic Mitigation Products Market Research Vectors………………… 45
2.5 COVID-19 Pandemic Mitigation R&D Challenges……………………………………. 45
2.6 Global COVID-19 Pandemic Mitigation Market – 2020-2024………………………… 46
2.6.1 Products & Services Groups Markets……………………………………………… 46
2.6.2 Products & Services Markets……… 50
2.6.3 Vertical Markets……………………….. 54
2.6.4 Revenue Source Markets…………… 55
2.6.5 Regional Markets……………………… 55
2.6.6 National Markets………………………. 56
3 The SARS‑CoV‑2 2019 Pandemic………….. 58
3.1 COVID-19 Basics…………………………… 58
3.2 COVID-19 Infection Rate…………………. 61
3.3 Social Distancing……………………………. 62
3.4 The Effect of Quarantine…………………. 64
3.5 Comparison of SARS-CoV-2 and Common Cold and Flu Viruses………….. 65
3.6 The SARS-CoV-2 Genome Information 66
3.7 Active Infection Testing…………………… 67
3.7.1 Nucleic Acid Detection………………. 67
3.7.2 Antigen Detection…………………….. 69
3.7.3 Other Technologies…………………… 69
3.8 Serology Testing……………………………. 70
4 Market Drivers…………………………………….. 73
5 Market Inhibitors…………………………………. 74
6 COVID-19 Pandemic Mitigation Products Market SWOT Analysis………………………… 75
6.1 Strengths……………………………………… 75
6.2 Weaknesses…………………………………. 76
6.3 Opportunities………………………………… 77
6.4 Threats………………………………………… 79
7 Business Opportunities & Challenges…… 81
8 COVID-19 Pandemic Mitigation Industry… 83
8.1 The COVID-19 Pandemic Mitigation Products Value Chain…………………….. 83
8.2 COVID-19 Pandemic Mitigation Products Industry Primary Activities……………….. 84
8.3 COVID-19 Pandemic Mitigation Products industry Support Activities……………….. 84
9 COVID-19 Pandemic Mitigation Products Industry: Barriers to Entry, Supplier Power, Buyer Power & Barriers to Substitution…. 86
GLOBAL MARKET……………………………………… 87
10 Global COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 87
10.1 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets – 2020-2024……………………………………. 87
10.1.1 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario A………. 87
10.1.1.1 Market Size…………………………… 87
10.1.1.2 Market Dynamics…………………… 89
10.1.1.3 Market Share………………………… 89
10.1.2 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario B………. 90
10.1.2.1 Market Size…………………………… 90
10.1.2.2 Market Dynamics…………………… 91
10.1.2.3 Market Share………………………… 92
10.1.3 Global COVID-19 Pandemic Mitigation Market: Scenarios Comparison…………………………….. 92
10.2 Global COVID-19 Pandemic Mitigation Products & Services Markets – 2020-2024…………………………………………………… 93
10.2.1 Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario A………………….. 94
10.2.1.1 Market Size…………………………… 94
10.2.1.2 Market Dynamics…………………… 96
10.2.2 Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario B………………….. 98
10.2.2.1 Market Size…………………………… 98
10.2.2.2 Market Dynamics………………….. 101
10.2.3 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenarios Comparison…………………………… 103
10.3 Global Vertical COVID-19 Pandemic Mitigation Markets – 2020-2024………. 104
10.3.1 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario A…………………………………………. 104
10.3.1.1 Market Size…………………………. 104
10.3.1.2 Market Dynamics………………….. 105
10.3.1.3 Market Share……………………….. 105
10.3.2 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario B…………………………………………. 106
10.3.2.1 Market Size…………………………. 106
10.3.2.2 Market Dynamics………………….. 106
10.3.2.3 Market Share……………………….. 107
10.3.3 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenarios Comparison…………………………… 107
10.4 Global COVID-19 Pandemic Mitigation Products & Services Market by Revenue Source – 2020-2024……………………… 108
10.4.1 Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario A………………….. 108
10.4.2 Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario B………………….. 109
10.4.3 Global COVID-19 Pandemic Mitigation Revenue Sources: Scenarios Comparison…………….. 111
10.5 Regional COVID-19 Pandemic Mitigation Markets – 2020-2024……………………. 112
10.5.1 Regional COVID-19 Pandemic Mitigation Market: Scenario A……. 112
10.5.1.1 Market Size…………………………. 112
10.5.1.2 Market Dynamics………………….. 112
10.5.1.3 Market Share……………………….. 113
10.5.2 Regional COVID-19 Pandemic Mitigation Market: Scenario B……. 113
10.5.2.1 Market Size…………………………. 113
10.5.2.2 Market Dynamics………………….. 114
10.5.2.3 Market Share……………………….. 114
10.5.3 Regional COVID-19 Pandemic Mitigation Market: Scenarios Comparison…………………………… 115
10.6 National COVID-19 Pandemic Mitigation Markets – 2020-2024……………………. 116
10.6.1 National COVID-19 Pandemic Mitigation Market: Scenario A……. 116
10.6.1.1 Market Size…………………………. 116
10.6.1.2 Market Dynamics………………….. 118
10.6.1.3 Market Shares……………………… 118
10.6.2 National COVID-19 Pandemic Mitigation Market: Scenario B……. 119
10.6.2.1 Market Size…………………………. 119
10.6.2.2 Market Dynamics………………….. 121
10.6.2.3 Market Share……………………….. 122
10.6.3 COVID-19 National Markets: Scenarios Comparison…………….. 122
[Back to top]
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 2
Download the PDF
PRODUCT/SERVICE MARKETS……………………. 32
1 COVID-19 Vaccines Market – 2020-2024… 32
1.1 COVID-19 Vaccines Market Background…………………………………………………… 32
1.1.1 Introduction……………………………… 32
1.1.2 Global COVID-19 Vaccine Development Funding……………….. 38
1.1.3 Vaccines Prices……………………….. 48
1.1.4 COVID-19 Vaccines Market: Conclusions…………………………….. 50
1.1.5 COVID-19 Vaccines:Business Opportunities…………………………… 53
1.1.6 COVID-19 Vaccines: Competitive Analysis: : Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………………… 54
1.1.7 Present and Potential Vendors……. 55
1.2 Global COVID-19 Pandemic Mitigation: Vaccines Market – 2020-2024………….. 58
1.2.1 Vaccines COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A………………………………. 58
1.2.2 Vaccines COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B………………………………. 59
2 COVID-19 Post-Infection Therapeutic Drugs Market – 2020-2024……………………………… 60
2.1 COVID-19 Post-Infection Therapies Drugs Market Background………………………… 60
2.1.1 Introduction……………………………… 60
2.1.2 Computer Aided COVID-19 Drug Research………………………………… 66
2.1.3 Adaptive Designs For COVID‑19 Clinical Trials…………………………… 67
2.1.4 COVID-19 Therapeutic Drugs Market: Conclusions…………………. 67
2.1.5 COVID-19 Therapeutic Drug :Business Opportunities…………….. 69
2.1.6 COVID-19 Post-Infection Therapeutic Drug: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………… 70
2.1.7 Present and Potential Vendors……. 71
2.2 Global COVID-19 Post-Infection Therapeutic Drugs Market – 2020-2024 74
2.2.1 COVID-19 Post Infection Therapeutic Drugs Market – 2020-2024: Scenario A…………………………………………… 74
2.2.2 Therapeutic Drugs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………… 75
3 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024.. 76
3.1 Other COVID-19 Pharma Industry Products Market Background…………… 76
3.1.1 Introduction and Findings…………… 76
3.1.2 Other COVID-19 Pharma Industry Products Market: Conclusions……. 78
3.1.3 Other COVID-19 Pharma Industry Products: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution…….. 79
3.2 Global COVID-19 Pandemic Mitigation: Other Pharma Industry Products Market – 2020-2024……………………………………. 80
3.2.1 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…. 80
3.2.2 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…. 80
4 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024.. 82
4.1 COVID-19 PCR Instrumentation & Software Market Background…………… 82
4.1.1 Introduction……………………………… 82
4.1.2 PCR Technologies & Procedures… 84
4.1.3 PCR Advantages……………………… 88
4.1.4 PCR Limitations……………………….. 88
4.1.5 PCR Based Coronavirus Diagnostics Used and Developed During January – April 2020……………………………. 90
4.1.6 Efforts to Develop and Disseminate a Test for COVID-19……………………. 91
4.1.7 PCR Purchasing Considerations…. 92
4.1.8 Costs of PCR Testing………………… 93
4.1.9 PCR Instrumentation & Software Market: Conclusions…………………. 93
4.1.10 PCR Instrumentation & Software: Business Opportunities……………… 94
4.1.11 PCR Instrumentation & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………….. 95
4.1.12 Key Vendors……………………………. 96
4.2 Global COVID-19 Pandemic Mitigation: PCR Instrumentation & Software Market – 2020-2024……………………………………. 96
4.2.1 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…. 97
4.2.2 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…. 97
5 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024.. 98
5.1 COVID-19 Robotic PCR Systems & Software Market Background…………… 98
5.1.1 Introduction and Findings…………… 98
5.1.2 Pooling PCR Method Testing Over 60 Samples Simultaneously……… 102
5.1.3 Robotic PCR Systems & Software Market: Conclusions………………… 102
5.1.4 Robotic PCR Systems & Software: Business Opportunities……………. 103
5.1.5 Robotic PCR Systems & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………… 104
5.2 Global COVID-19 Pandemic Mitigation: Robotic PCR Systems & Software Market – 2020-2024………………………………… 105
5.2.1 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 105
5.2.2 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 106
6 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024 107
6.1 COVID-19 PCR Reagents & Consumables Market Background…… 107
6.1.1 Introduction……………………………. 107
6.1.2 PCR Reagents & Consumables Market: Conclusions………………… 108
6.1.3 PCR Reagents & Consumables: Business Opportunities……………. 109
6.1.4 PCR Reagents & Consumables: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………… 110
6.2 1.2 Global COVID-19 Pandemic Mitigation: PCR Reagents & Consumables Market – 2020-2024….. 111
6.2.1 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 111
6.2.2 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 112
7 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 113
7.1 COVID-19 Nose & Mouth Swabs Market Background…………………………………. 113
7.1.1 Introduction and Findings…………. 113
7.1.2 Nose & Mouth Swabs: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………………. 116
7.2 Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Market – 2020-2024………………………………………….. 117
7.2.1 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 117
7.2.2 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 117
8 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024 119
8.1 COVID-19 Self-collection PCR Test Kits Market Background………………………. 119
8.1.1 Saliva Tests…………………………… 120
8.2 COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Market – 2020-2024………………………………………….. 122
8.2.1 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 123
8.2.2 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 123
9 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 124
9.1 COVID-19 Serologic Test Kits Market Background…………………………………. 124
9.1.1 Introduction and Findings…………. 124
9.1.2 FDA Statement Related to the Status of Serological (Antibody) Tests….. 130
9.1.3 Coronavirus Antibody Test Kits….. 131
9.1.4 Serologic Test Kits Market: Conclusions…………………………… 135
9.1.5 Serologic Test Kits: Business Opportunities…………………………. 137
9.1.6 Serologic Test Kits: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………………. 138
9.1.7 Key Vendors………………………….. 139
9.2 Global COVID-19 Pandemic Mitigation: Serologic Test Kits Market – 2020-2024…………………………………………………. 139
9.2.1 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 139
9.2.2 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 140
10 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 141
10.1 COVID-19 Standoff Thermometry Market Background…………………………………. 141
10.1.1 Introduction and Findings…………. 141
10.1.2 Standoff Thermometry Market: Conclusions…………………………… 144
10.1.3 Standoff Thermometry: Business Opportunities…………………………. 145
10.1.4 Key Vendors………………………….. 145
10.2 Global COVID-19 Pandemic Mitigation: Standoff Thermometry Market – 2020-2024………………………………………….. 145
10.2.1 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 146
10.2.2 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 146
11 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 147
11.1 COVID-19 X-Ray Procedures Market Background…………………………………. 147
11.1.1 Introduction and Findings…………. 147
11.1.2 X-Ray Procedures Market: Conclusions…………………………… 152
11.1.3 Key Vendors………………………….. 153
11.2 Global COVID-19 Pandemic Mitigation: X-Ray Procedures Market – 2020-2024. 153
11.2.1 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 154
11.2.2 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 154
12 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 155
12.1 COVID-19 CT Procedures Market Background…………………………………. 155
12.1.1 Introduction and Findings…………. 155
12.1.2 CT Procedures Market: Conclusions……………………………………………. 158
12.1.3 CT Procedures: Business Opportunities…………………………. 159
12.1.4 Key Vendors………………………….. 159
12.2 Global COVID-19 Pandemic Mitigation: CT Procedures Market – 2020-2024… 159
12.2.1 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 160
12.2.2 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 160
13 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 162
13.1 COVID-19 Ultrasound Procedures Market Background…………………………………. 162
13.1.1 Introduction and Findings…………. 162
13.1.2 FDA Approved “ EMT & Field” Smartphone-Tablet Based Coronavirus Chest Ultrasound…… 164
13.1.3 COVID-19 Chest Ultrasound Diagnostics……………………………. 164
13.1.4 Ultrasound Procedures Market: Conclusions…………………………… 165
13.1.5 Ultrasound Procedures: Business Opportunities…………………………. 166
13.1.6 Key Vendors………………………….. 166
13.2 Global COVID-19 Pandemic Mitigation: Ultrasound Procedures Market – 2020-2024………………………………………….. 167
13.2.1 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 167
13.2.2 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 167
14 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 169
14.1 COVID-19 FDG-PET/CT Procedures & Wastewater Testing Market Background…………………………………………………. 169
14.1.1 Introduction and Findings…………. 169
14.1.2 FDG-PET/CT Procedures…………. 170
14.1.3 COVID-19 Wastewater Testing….. 171
14.1.4 FDG-PET/CT Procedures & Wastewater Testing Market: Conclusions…………………………… 173
14.1.5 FDG-PET/CT Procedures & Wastewater Testing: Business Opportunities…………………………. 173
14.1.6 Key Vendors………………………….. 173
14.2 Global COVID-19 Pandemic Mitigation: FDG-PET/CT Procedures & Wastewater Testing Market – 2020-2024…………… 173
14.2.1 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 174
14.2.2 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 174
15 PACS & Teleradiology COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 176
15.1 PACS & Teleradiology Market Background…………………………………. 176
15.1.1 Introduction and Findings…………. 176
15.1.2 The FDA PACS & Teleradiography COVID-19 Pandemic Policy………. 180
15.1.3 PACS & Teleradiology Market: Conclusions…………………………… 181
15.1.4 PACS & Teleradiology: Business Opportunities…………………………. 181
15.1.5 Key Vendors………………………….. 182
15.2 Global COVID-19 Pandemic Mitigation: PACS & TeleradiologyMarket – 2020-2024………………………………………….. 182
15.2.1 PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 183
15.2.2 PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 183
16 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 184
16.1 Pandemic PPE Gowns Market Background…………………………………. 184
16.1.1 Introduction and Findings…………. 184
16.1.2 PPE Gowns Market: Conclusions 190
16.1.3 PPE Gowns: Business Opportunities……………………………………………. 190
16.2 Global COVID-19 Pandemic Mitigation: PPE Gowns Market – 2020-2024…….. 191
16.2.1 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 191
16.2.2 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 192
17 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 193
17.1 COVID-19 Gloves Market Background 193
17.1.1 Introduction and Findings…………. 193
17.1.2 Gloves Market: Conclusions…….. 194
17.1.3 Gloves: Business Opportunities…. 194
17.2 Global COVID-19 Pandemic Mitigation: Gloves Market – 2020-2024…………… 195
17.2.1 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 195
17.2.2 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 196
18 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 197
18.1 Medical Face Masks Market Background…………………………………………………. 197
18.1.1 Introduction and Findings…………. 197
18.1.2 N95 Masks Vs. Surgical Mask…… 198
18.1.3 Face Masks Precautions………….. 203
18.1.4 Face Masks Market: Conclusions 204
18.1.5 Face Masks: Business Opportunities……………………………………………. 204
18.1.6 Key Vendors………………………….. 204
18.2 Global COVID-19 Pandemic Mitigation: Face Masks Market – 2020-2024…….. 205
18.2.1 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 206
18.2.2 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 206
19 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 207
19.1 Medical Face Shields Market Background…………………………………………………. 207
19.1.1 Introduction and Findings…………. 207
19.1.2 Face Shields Standards…………… 209
19.2 Global COVID-19 Pandemic Mitigation: Medical Face Shields Market – 2020-2024…………………………………………………. 210
19.2.1 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 210
19.2.2 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 211
20 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 212
20.1 Pandemic Eye Protection Market Background…………………………………. 212
20.1.1 Introduction and Findings…………. 212
20.1.2 Key Vendors………………………….. 213
20.2 Global COVID-19 Pandemic Mitigation: Eye Protection Market – 2020-2024…. 214
20.2.1 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 214
20.2.2 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 215
21 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 216
21.1 Global COVID-19 Pandemic Mitigation: PPE Sterilization: Systems & Consumables Market – 2020-2024….. 216
21.1.1 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 216
21.1.2 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 217
22 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024 218
22.1 Hand & Surface Sanitizers Market Background…………………………………. 218
22.2 Global COVID-19 Pandemic Mitigation: Hand & Surface Sanitizers Market – 2020-2024………………………………………….. 221
22.2.1 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 221
22.2.2 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 222
23 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 223
23.1 Decontamination Market Background. 223
23.1.1 Introduction……………………………. 223
23.1.2 Definitions……………………………… 224
23.1.3 Timing and Location Of Cleaning And Disinfection Of Surfaces…………… 224
23.1.4 Hard (Non-porous) Surfaces……… 225
23.1.5 Soft (Porous) Surfaces…………….. 225
23.1.6 Electronics…………………………….. 225
23.1.7 Linens, Clothing, and Other Items That Go in the Laundry…………….. 226
23.1.8 Risk of Exposure…………………….. 226
23.1.9 Considerations for Employers……. 227
23.1.10 Decontamination Market: Conclusions…………………………… 227
23.2 Global COVID-19 Pandemic Mitigation: Decontamination Market – 2020-2024 228
23.2.1 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 229
23.2.2 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 229
24 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024 231
24.1 Global COVID-19 Pandemic Mitigation: Other Personal Protection Gear Market – 2020-2024………………………………….. 231
24.1.1 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 231
24.1.2 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 232
25 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024 233
25.1 Pandemic AI, Big Data & Deep Learning Market Background………………………. 233
25.1.1 Introduction and Findings…………. 233
25.1.2 AI Based Early Warnings and Alerts……………………………………………. 235
25.1.3 Tracking and Prediction……………. 235
25.1.4 Data Dashboards……………………. 237
25.1.5 Diagnosis and Prognosis………….. 237
25.1.6 COVID-19 Treatments Optimization……………………………………………. 238
25.1.7 COVID-19 Pandemic Social Control……………………………………………. 239
25.1.8 Pandemic Outbreak Forecasting.. 240
25.1.9 AI, Big-Data and Deep Learning Assisted CT Imaging……………….. 242
25.1.10 AI, Big-Data and Deep-Learning Assisted COVID-19 Treatment….. 243
25.1.11 COVID-19: AI Assisted X-rays Imaging………………………………… 244
25.1.12 COVID-19 AI, Big Data & Deep Learning……………………………….. 244
25.1.13 AI Assisted Pandemic Symptoms Analysis………………………………… 246
25.1.14 AI, Big Data & Deep Learning Market: Conclusions…………………………… 247
25.1.15 AI, Big Data & Deep Learning: Business Opportunities……………. 248
25.1.16 Key Vendors………………………….. 248
25.2 Global COVID-19 Pandemic Mitigation: AI, Big Data & Deep Learning Market – 2020-2024………………………………….. 250
25.2.1 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 250
25.2.2 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 250
26 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 252
26.1 Pandemic Homecare IT Market Background…………………………………. 252
26.1.1 Introduction and Findings…………. 252
26.1.2 Homecare IT Market: Conclusions……………………………………………. 253
26.1.3 Homecare IT: Business Opportunities……………………………………………. 254
26.1.4 Key Vendors………………………….. 254
26.2 Global COVID-19 Pandemic Mitigation: Homecare IT Market – 2020-2024…… 255
26.2.1 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 255
26.2.2 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 255
27 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 257
27.1 Pandemic Geo-Surveillance Systems & Services Market Background………….. 257
27.1.1 Introduction and Findings…………. 257
27.1.2 MIT “Private Kit”……………………… 263
27.1.3 The UK NHS COVID-19 App…….. 265
27.1.4 Companies Making Cell Location Tracking Technology……………….. 266
27.2 Global COVID-19 Pandemic Mitigation: Geo-Surveillance Systems & Services Market – 2020-2024……………………… 270
27.2.1 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 271
27.2.2 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 271
28 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 272
28.1 Pandemic E-Health Market Background…………………………………………………. 272
28.1.1 Introduction and Findings…………. 272
28.1.2 E-Health Market: Conclusions….. 274
28.1.3 E-Health: Business Opportunities. 275
28.1.4 Key Vendors………………………….. 275
28.2 Global COVID-19 Pandemic Mitigation: E-Health Market – 2020-2024……………. 275
28.2.1 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 276
28.2.2 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 276
29 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024 277
29.1 Pandemic Blockchain Technologies Market Background………………………. 277
29.1.1 Introduction and Findings…………. 277
29.1.2 Blockchain in Healthcare………….. 279
29.1.3 Blockchain Applications……………. 279
29.1.4 Blockchain Technologies Market: Conclusions…………………………… 282
29.1.5 Blockchain Technologies: Business Opportunities…………………………. 283
29.1.6 Key Vendors………………………….. 283
29.2 Global COVID-19 Pandemic Mitigation: Blockchain Technologies Market – 2020-2024………………………………………….. 284
29.2.1 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 284
29.2.2 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 285
30 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 286
30.1 Other Pandemics ICT Market Background…………………………………………………. 286
30.1.1 Introduction and Findings…………. 286
30.1.2 Other ICT Market: Conclusions…. 288
30.1.3 Other ICT: Business Opportunities 289
30.1.4 Vendors………………………………… 289
30.2 Global COVID-19 Pandemic Mitigation: Other ICT Market – 2020-2024……….. 290
30.2.1 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 291
30.2.2 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 291
31 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024 293
31.1 Non-Invasive Ventilators Market Background…………………………………. 293
31.1.1 Introduction and Findings…………. 293
31.1.2 The U.S. HHS Procurement Contracts On Non-Invasive Ventilators With Ten Vendors………………………….. 299
31.1.3 Helmet-Based Non-invasive Ventilators…………………………….. 299
31.1.4 Non-invasive Ventilators Market: Conclusions…………………………… 300
31.1.5 Business Opportunities……………. 301
31.1.6 Non-invasive Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution……………………………. 302
31.1.7 Key Vendors………………………….. 303
31.2 Global COVID-19 Pandemic Mitigation: Noninvasive Ventilators Market – 2020-2024………………………………………….. 303
31.2.1 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 303
31.2.2 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 304
32 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024 305
32.1 Invasive Mechanical Ventilators Market Background…………………………………. 305
32.1.1 Introduction and Findings…………. 305
32.1.2 Challenges of Traditional Mechanical Ventilation Devices………………….. 312
32.1.2.1 Difficult To Expand Capacity And Limited Portability…………………. 312
32.1.2.2 Complex and Time Consuming To Administer Care……………………. 312
32.1.2.3 Difficult To Switch Between Therapies……………………………. 313
32.1.3 Invasive Mechanical Ventilators Market: Conclusions………………… 313
32.1.4 Invasive Mechanical Ventilators: Business Opportunities……………. 313
32.1.5 Invasive Mechanical Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution………. 315
32.1.6 Key Vendors………………………….. 316
32.2 Global COVID-19 Pandemic Mitigation: Invasive Mechanical Ventilators Market – 2020-2024………………………………….. 316
32.2.1 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 316
32.2.2 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 317
33 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024 318
33.1 Next Generation Ventilators Market Background…………………………………. 318
33.1.1 Introduction and Findings…………. 318
33.1.2 Next Generation Ventilators Market: Conclusions…………………………… 319
33.1.3 Next Generation Ventilators: Business Opportunities…………………………. 320
33.1.4 Next Generation Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution………. 321
33.2 Global COVID-19 Pandemic Mitigation: Next Generation Ventilators Market – 2020-2024………………………………….. 322
33.2.1 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 322
33.2.2 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 322
34 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 324
34.1 COVID-19 Homecare “ICU” (Equipment, Software, Services) Market Background…………………………………………………. 324
34.1.1 Introduction and Findings…………. 324
34.1.2 WHO Protocol For COVID-19 Homecare……………………………… 327
34.1.3 Homecare Market: Conclusions…. 328
34.1.4 Homecare Business Opportunities 329
34.1.5 Homecare: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution……………………………. 330
34.1.6 Key Vendors………………………….. 331
34.2 Global COVID-19 Pandemic Mitigation: Homecare “ICU” (Equipment, Software, Services) Market – 2020-2024………… 331
34.2.1 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 332
34.2.2 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 332
34.3 Portable Ventilators Market Background…………………………………………………. 333
34.3.1 Introduction and Findings…………. 333
34.3.2 Portable Ventilators Market: Conclusions…………………………… 336
34.3.3 Key Vendors………………………….. 336
34.4 Global COVID-19 Pandemic Mitigation: Mobile Ventilators Market – 2020-2024…………………………………………………. 337
34.4.1 Mobile Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 337
34.4.2 Mobile Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 338
35 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024 339
35.1 Surge Capacity Hospitals Market Background…………………………………. 339
35.1.1 Introduction and Findings…………. 339
35.1.2 Surge Capacity Hospitals Market: Conclusions…………………………… 342
35.2 Global COVID-19 Pandemic Mitigation: Surge Capacity Hospitals Market – 2020-2024………………………………………….. 342
35.2.1 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 342
35.2.2 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 343
36 Kidney Dialysis COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 344
36.1 Kidney Dialysis Systems Market Background…………………………………. 344
36.1.1 Introduction and Findings…………. 344
36.1.2 Kidney Dialysis Systems Market: Conclusions…………………………… 347
36.1.3 Kidney Dialysis Systems: Business Opportunities…………………………. 347
36.1.4 Key Vendors………………………….. 347
36.2 Global COVID-19 Pandemic Mitigation: Kidney Dialysis Market – 2020-2024… 348
36.2.1 Kidney DialysisCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 348
36.2.2 Kidney DialysisCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 349
37 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 350
37.1 Extracorporeal Membrane Oxygenation Procedures Market Background………. 350
37.1.1 Introduction and Findings…………. 350
37.1.2 The FDA Extracorporeal Membrane Oxygenation (ECMO) Policy……… 353
37.1.3 Extracorporeal Membrane Oxygenation Procedures Market: Conclusions…………………………… 354
37.1.4 Extracorporeal Membrane Oxygenation Procedures: Business Opportunities…………………………. 355
37.1.5 Key Vendors………………………….. 355
37.2 Global COVID-19 Pandemic Mitigation: Extracorporeal Membrane Oxygenation Procedures Market – 2020-2024……… 356
37.2.1 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 356
37.2.2 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 356
38 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024 358
38.1 Other Intensive Care Modalities Market Background…………………………………. 358
38.1.1 Introduction and Findings…………. 358
38.1.2 Other Intensive Care Modalities Market: Conclusions………………… 361
38.2 Global COVID-19 Pandemic Mitigation: Other Intensive Care Modalities Market – 2020-2024………………………………….. 362
38.2.1 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 362
38.2.2 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 362
39 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 364
39.1 PPE Gowns Manufacturing Plants Market Background…………………………………. 364
39.1.1 Introduction and Findings…………. 364
39.1.2 Gowns Manufacturing Plants Market: Conclusions…………………………… 366
39.1.3 Gowns Manufacturing Plants: Business Opportunities……………. 366
39.2 Global COVID-19 Pandemic Mitigation: Gowns Manufacturing Plants Market – 2020-2024………………………………….. 366
39.2.1 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 367
39.2.2 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 367
40 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 369
40.1 Medical PPE Gloves Manufacturing Plants Market Background……………… 369
40.1.1 Introduction and Findings…………. 369
40.1.2 Medical PPE Gloves Manufacturing Plants Market: Conclusions……… 371
40.1.3 Medical PPE Gloves Manufacturing Plants: Business Opportunities….. 372
40.2 Global COVID-19 Pandemic Mitigation: Gloves Manufacturing Plants Market – 2020-2024………………………………….. 372
40.2.1 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 373
40.2.2 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 373
41 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 375
41.1 Face Masks Manufacturing Plants Market Background…………………………………. 375
41.1.1 Introduction and Findings…………. 375
41.1.2 N95 Respirators Manufacturing…. 383
41.1.3 Face Masks Manufacturing Plants Market: Conclusions………………… 385
41.1.4 Face Masks Manufacturing Plants: Business Opportunities……………. 386
41.1.5 Key Vendors………………………….. 386
41.2 Global COVID-19 Pandemic Mitigation: Face Masks Manufacturing Plants Market – 2020-2024………………………………… 387
41.2.1 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 387
41.2.2 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 387
42 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 389
42.1 Face Shields Manufacturing Plants Market Background………………………. 389
42.1.1 Introduction and Findings…………. 389
42.2 Global COVID-19 Pandemic Mitigation: Face Shields Manufacturing Plants Market – 2020-2024……………………… 391
42.2.1 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 391
42.2.2 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 392
43 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 393
43.1 Serologic Test Kits Manufacturing Plants Market Background………………………. 393
43.1.1 Introduction and Findings…………. 393
43.1.2 Serologic Test Kits Manufacturing Plants Market: Conclusions……… 394
43.2 Global COVID-19 Pandemic Mitigation: Serologic Test Kits Manufacturing Plants Market – 2020-2024……………………… 395
43.2.1 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 395
43.2.2 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 395
44 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 397
44.1 Melt-Blown PPE Fabric Manufacturing Plants Market Background……………… 397
44.1.1 Introduction and Findings…………. 397
44.1.2 Melt-Blown PPE Fabric. Manufacturing Plants Market: Conclusions…………………………… 401
44.2 Global COVID-19 Pandemic Mitigation: Melt-Blown PPE Fabric Manufacturing Plants Market – 2020-2024…………….. 402
44.2.1 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 403
44.2.2 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 403
45 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 405
45.1 Spun-Bond PPE Fabric Manufacturing Plants Market Background……………… 405
45.1.1 Introduction and Findings…………. 405
45.1.2 Spun-Bond PPE Fabric Manufacturing Plants Market: Conclusions……… 406
45.2 Global COVID-19 Pandemic Mitigation: Spun-Bond PPE Fabric Manufacturing Plants Market – 2020-2024…………….. 408
45.2.1 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 408
45.2.2 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 408
46 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 410
46.1 Market Background………………………. 410
46.2 Global COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Manufacturing Plants Market – 2020-2024…………………………………………………. 411
46.2.1 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 411
46.2.2 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 412
47 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 413
47.1 Ventilators Manufacturing Plants Market Background…………………………………. 413
47.1.1 Introduction and Findings…………. 413
47.1.2 Ventilators Manufacturing Plants Market: Conclusions………………… 416
47.2 Global COVID-19 Pandemic Mitigation: Ventilators Manufacturing Plants Market – 2020-2024………………………………….. 417
47.2.1 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 418
47.2.2 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 418
48 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 419
48.1 Global COVID-19 Pandemic Mitigation: PCR Reagents Manufacturing Plants Market – 2020-2024……………………… 419
48.1.1 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 419
48.1.2 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 420
49 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 421
49.1 Global COVID-19 Pandemic Mitigation: PCR Systems Manufacturing Plants Market – 2020-2024……………………… 421
49.1.1 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 421
49.1.2 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 422
50 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 423
50.1 Nose & Mouth Swabs Manufacturing Plants Market Background……………… 423
50.1.1 Introduction and Findings…………. 423
50.1.2 Swabs Manufacturing Plants Market: Conclusions…………………………… 425
50.1.3 Swabs Manufacturing Plants: Business Opportunities……………. 426
50.2 Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Manufacturing Plants Market – 2020-2024…………….. 426
50.2.1 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 427
50.2.2 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 427
51 Medical Glass & Other Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 428
51.1 Global COVID-19 Pandemic Mitigation: Medical Glass & Other Manufacturing Plants Market – 2020-2024…………….. 428
51.1.1 Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 428
51.1.2 Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 429
52 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024 430
52.1 Global COVID-19 Pandemic Mitigation: R&D Equipment & Consumables Market – 2020-2024………………………………….. 430
52.1.1 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 430
52.1.2 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 431
53 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 432
53.1 Medical Glass and Other Products & Services Market Background………….. 432
53.1.1 Medical Glass Introduction and Findings………………………………… 432
53.1.2 Medical Glass Market: Conclusions……………………………………………. 433
53.1.3 Key Medical Glass Vendors………. 433
53.2 Global COVID-19 Pandemic Mitigation: Medical Glass and Other Products & Services Market – 2020-2024…………. 433
53.2.1 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 434
53.2.2 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 434
[Back to top]
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 3
Download the PDF
VERTICAL MARKETS…………………………………. 14
1 Hospitals and Surge Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024.. 14
1.1 Market Background………………………… 14
1.2 Global COVID-19 Pandemic Mitigation: Hospitals and Surge Hospitals Market – 2020-2024……………………………………. 14
1.2.1 COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario A…………………… 15
1.2.2 COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario B…………………… 16
1.2.3 Hospitals and Surge Hospitals Market: Scenarios Comparison…… 18
2 Clinical Labs COVID-19 Pandemic Mitigation Market – 2020-2024………………. 19
2.1 Market Background………………………… 19
2.2 Global COVID-19 Pandemic Mitigation: Clinical Labs Market – 2020-2024……… 19
2.2.1 COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario A…. 20
2.2.2 COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario B…. 21
2.2.3 Clinical Labs Market: Scenarios Comparison…………………………….. 23
3 Clinics COVID-19 Pandemic Mitigation Market – 2020-2024……………………………… 24
3.1 Market Background………………………… 24
3.2 Global COVID-19 Pandemic Mitigation: Clinics Market – 2020-2024……………… 24
3.2.1 COVID-19 Pandemic Mitigation Clinics Market: Scenario A…………. 25
3.2.2 COVID-19 Pandemic Mitigation Clinics Market: Scenario B…………. 26
3.2.3 Clinics Market: Scenarios Comparison……………………………………………… 28
4 Emergency Medical Services (EMS) COVID-19 Pandemic Mitigation Market – 2020-2024 29
4.1 Market Background………………………… 29
4.2 Global COVID-19 Pandemic Mitigation: Emergency Medical Services (EMS) Market – 2020-2024……………………….. 29
4.2.1 COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario A…………………… 30
4.2.2 COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario B…………………… 31
4.2.3 Emergency Medical Services Market: Scenarios Comparison………………. 33
5 Homecare & Nursing Homes COVID-19 Pandemic Mitigation Market – 2020-2024.. 34
5.1 Market Background………………………… 34
5.2 Global COVID-19 Pandemic Mitigation: Homecare & Nursing Homes Market – 2020-2024……………………………………. 34
5.2.1 COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario A………………………………. 35
5.2.2 COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario B………………………………. 36
5.2.3 Homecare & Nursing Homes Market: Scenarios Comparison………………. 38
6 Research Bodies COVID-19 Pandemic Mitigation Market – 2020-2024………………. 39
6.1 Market Background………………………… 39
6.2 Global COVID-19 Pandemic Mitigation: Research Bodies Market – 2020-2024.. 39
6.2.1 COVID-19 Pandemic Mitigation Research Bodies Market: Scenario A……………………………………………… 40
6.2.2 COVID-19 Pandemic Mitigation Research Bodies Market: Scenario B……………………………………………… 41
6.2.3 Research Bodies Market: Scenarios Comparison…………………………….. 43
REGIONAL MARKETS………………………………… 44
7 North America COVID-19 Pandemic Mitigation Market – 2020-2024……………….. 44
7.1 North America Vertical Markets – 2020-2024……………………………………………. 44
7.1.1 North America COVID-19 Pandemic Mitigation Market: Scenario A……… 44
7.1.2 North America COVID-19 Pandemic Mitigation Market: Scenario B……… 46
7.1.3 Scenarios Comparison………………. 48
7.2 North America COVID-19 Pandemic Mitigation Market by Revenue Source – 2020-2024……………………………………. 49
7.2.1 North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A…………………… 49
7.2.2 North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B…………………… 51
8 Europe COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 53
8.1 Europe Vertical Markets – 2020-2024… 53
8.1.1 Europe COVID-19 Pandemic Mitigation Market: Scenario A……… 53
8.1.2 Europe COVID-19 Pandemic Mitigation Market: Scenario B……… 55
8.1.3 Scenarios Comparison………………. 57
8.2 Europe COVID-19 Market by Revenue Source – 2020-2024……………………….. 58
8.2.1 Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario A…………………… 58
8.2.2 Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario B…………………… 60
9 Asia-Pacific COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 61
9.1 Asia-Pacific Vertical Markets – 2020-2024…………………………………………………… 61
9.1.1 Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario A……… 61
9.1.2 Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario B……… 63
9.1.3 Scenarios Comparison………………. 64
9.2 Asia-Pacific COVID-19 Market by Revenue Source – 2020-2024………….. 65
9.2.1 Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario A…………………… 65
9.2.2 Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario B…………………… 67
10 MEA & Latin America COVID-19 Pandemic Mitigation Market – 2020-2024……………….. 69
10.1 MEA & Latin America Vertical Markets – 2020-2024……………………………………. 69
10.1.1 MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario A…………………………………………… 69
10.1.2 MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario B…………………………………………… 71
10.1.3 Scenarios Comparison………………. 73
10.2 MEA & Latin America COVID-19 Market by Revenue Source – 2020-2024……… 74
10.2.1 MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A………. 74
10.2.2 MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B………. 76
NATIONAL MARKETS…………………………………. 78
11 USA COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 78
11.1 Market Background………………………… 78
11.2 USA COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 79
12 Canada COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 81
12.1 Market Background………………………… 81
12.2 Canada COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 82
13 U.K. COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 84
13.1 Market Background………………………… 84
13.2 U.K. COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 85
14 Germany COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 87
14.1 Market Background………………………… 87
14.2 Germany COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 88
15 France COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 90
15.1 Market Background………………………… 90
15.2 France COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 91
16 Italy COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 93
16.1 Market Background………………………… 93
16.2 Italy COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 94
17 Rest of Europe COVID-19 Pandemic Mitigation Market – 2020-2024……………….. 96
18 India COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 98
18.1 Market Background………………………… 98
18.2 India COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 99
19 China COVID-19 Pandemic Mitigation Market – 2020-2024…………………………….. 101
19.1 Market Background………………………. 101
19.2 China COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………… 102
20 South Korea COVID-19 Pandemic Mitigation Market – 2020-2024…………………………….. 104
20.1 Market Background………………………. 104
20.2 South Korea COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024…………………………………………………. 105
21 Japan COVID-19 Pandemic Mitigation Market – 2020-2024…………………………….. 107
21.1 Market Background………………………. 107
21.2 Japan COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………… 108
22 Rest of Asia-Pacific COVID-19 Pandemic Mitigation Market – 2020-2024……………… 110
23 ROW COVID-19 Pandemic Mitigation Market – 2020-2024……………………………………….. 112
[Back to top]
Global Homeland Security & Public Safety Market – 2020-2024: Volume 4
Download the PDF
MAJOR VENDORS……………………………………….. 8
1 Vendor 1………………………………………………. 8
1.1 Company Profile……………………………… 8
1.2 2017- 2019 Financials………………………. 8
1.3 COVID-19 Mitigation Activities & Products………………………………………… 9
2 Vendor 2…………………………………………….. 11
2.1 Company Profile……………………………. 11
2.2 2017- 2019 Financials…………………….. 11
2.3 COVID-19 Mitigation Activities & Products………………………………………. 12
3 Vendor 3…………………………………………….. 13
3.1 Company Profile……………………………. 13
3.2 2017- 2018 Financials…………………….. 13
3.3 COVID-19 Mitigation Activities & Products………………………………………. 14
4 Vendor 4…………………………………………….. 15
4.1 Company Profile……………………………. 15
4.2 2017- 2018 Financials…………………….. 15
4.3 COVID-19 Mitigation Activities & Products………………………………………. 16
5 Vendor 5…………………………………………….. 17
5.1 Company Profile……………………………. 17
5.2 2017- 2019 Financials…………………….. 17
5.3 COVID-19 Mitigation Activities & Products………………………………………. 17
6 Vendor 6…………………………………………….. 18
6.1 Company Profile……………………………. 18
6.2 2017- 2018 Financials…………………….. 18
6.3 COVID-19 Mitigation Activities & Products………………………………………. 18
7 Vendor 7…………………………………………….. 19
7.1 Company Profile……………………………. 19
7.2 2017- 2019 Financials…………………….. 19
7.3 COVID-19 Mitigation Activities & Products………………………………………. 20
8 Vendor 8…………………………………………….. 21
8.1 Company Profile……………………………. 21
8.2 2017- 2019 Financials…………………….. 21
8.3 COVID-19 Mitigation Activities & Products………………………………………. 22
9 Vendor 9…………………………………………….. 23
9.1 Company Profile……………………………. 23
9.2 2017- 2019 Financials…………………….. 24
9.3 COVID-19 Mitigation Activities & Products………………………………………. 24
10 Vendor 10…………………………………………… 26
10.1 Company Profile……………………………. 26
10.2 2017- 2019 Financials…………………….. 26
10.3 COVID-19 Mitigation Activities & Products………………………………………. 26
11 Vendor 11…………………………………………… 27
11.1 Company Profile……………………………. 27
11.2 2017- 2019 Financials…………………….. 27
11.3 COVID-19 Mitigation Activities & Products………………………………………. 28
12 Vendor 12…………………………………………… 29
12.1 Company Profile……………………………. 29
12.2 2017- 2019 Financials…………………….. 30
12.3 COVID-19 Mitigation Activities & Products………………………………………. 30
13 Vendor 13…………………………………………… 31
13.1 Company Profile……………………………. 31
13.2 2017- 2019 Financials…………………….. 31
13.3 COVID-19 Mitigation Activities & Products………………………………………. 32
14 Vendor 14…………………………………………… 33
14.1 Company Profile……………………………. 33
14.2 2017- 2019 Financials…………………….. 34
14.3 COVID-19 Mitigation Activities & Products………………………………………. 34
15 Vendor 15…………………………………………… 35
15.1 Company Profile……………………………. 35
15.2 2017- 2019 Financials…………………….. 36
15.3 COVID-19 Mitigation Activities & Products………………………………………. 36
16 Vendor 16…………………………………………… 37
16.1 Company Profile……………………………. 37
16.2 2017- 2019 Financials…………………….. 38
16.3 COVID-19 Mitigation Activities & Products………………………………………. 38
17 Vendor 17…………………………………………… 40
17.1 Company Profile……………………………. 40
17.2 2017- 2019 Financials…………………….. 40
17.3 COVID-19 Mitigation Activities & Products………………………………………. 41
18 Vendor 18…………………………………………… 42
18.1 Company Profile……………………………. 42
18.2 2017- 2019 Financials…………………….. 42
18.3 COVID-19 Mitigation Activities & Products………………………………………. 43
19 Vendor 19…………………………………………… 44
19.1 Company Profile……………………………. 44
19.2 2017- 2019 Financials…………………….. 44
19.3 COVID-19 Mitigation Activities & Products………………………………………. 44
20 Vendor 20…………………………………………… 45
20.1 Company Profile……………………………. 45
20.2 2016- 2018 Financials…………………….. 45
20.3 COVID-19 Mitigation Activities & Products………………………………………. 46
21 Vendor 21…………………………………………… 46
21.1 Company Profile……………………………. 47
21.2 2017- 2019 Financials…………………….. 47
21.3 COVID-19 Mitigation Activities & Products………………………………………. 48
22 Vendor 22…………………………………………… 49
22.1 Company Profile……………………………. 49
22.2 2017- 2019 Financials…………………….. 49
22.3 COVID-19 Mitigation Activities & Products………………………………………. 50
23 Vendor 23…………………………………………… 51
23.1 Company Profile……………………………. 51
23.2 2017- 2019 Financials…………………….. 51
23.3 COVID-19 Mitigation Activities & Products………………………………………. 52
24 Vendor 24…………………………………………… 52
24.1 Company Profile……………………………. 53
24.2 2017- 2019 Financials…………………….. 53
24.3 COVID-19 Mitigation Activities & Products………………………………………. 54
25 Vendor 25…………………………………………… 54
25.1 Company Profile……………………………. 55
25.2 2017- 2019 Financials…………………….. 55
25.3 COVID-19 Mitigation Activities & Products………………………………………. 56
26 Vendor 26…………………………………………… 56
26.1 Company Profile……………………………. 57
26.2 2017- 2019 Financials…………………….. 57
26.3 COVID-19 Mitigation Activities & Products………………………………………. 57
27 Vendor 27…………………………………………… 59
27.1 Company Profile……………………………. 59
27.2 2017- 2019 Financials…………………….. 60
27.3 COVID-19 Mitigation Activities & Products………………………………………. 60
28 Vendor 28…………………………………………… 61
28.1 Company Profile……………………………. 61
28.2 2017- 2019 Financials…………………….. 62
28.3 COVID-19 Mitigation Activities & Products………………………………………. 62
29 Vendor 29…………………………………………… 64
29.1 Company Profile……………………………. 64
29.2 2017- 2019 Financials…………………….. 64
29.3 COVID-19 Mitigation Activities & Products………………………………………. 65
30 Vendor 30…………………………………………… 66
30.1 Company Profile……………………………. 66
30.2 2017- 2019 Financials…………………….. 66
30.3 COVID-19 Mitigation Activities & Products………………………………………. 66
31 Vendor 31…………………………………………… 67
31.1 Company Profile……………………………. 67
31.2 2017- 2019 Financials…………………….. 67
31.3 COVID-19 Mitigation Activities & Products………………………………………. 67
32 Vendor 32…………………………………………… 68
32.1 Company Profile……………………………. 68
32.2 2017- 2019 Financials…………………….. 68
32.3 COVID-19 Mitigation Activities & Products………………………………………. 69
33 Vendor 33…………………………………………… 69
33.1 Company Profile……………………………. 70
33.2 2017- 2019 Financials…………………….. 70
33.3 COVID-19 Mitigation Activities & Products………………………………………. 71
34 Vendor 34…………………………………………… 71
34.1 Company Profile……………………………. 72
34.2 2008- 2010 Financials…………………….. 73
34.3 COVID-19 Mitigation Activities & Products………………………………………. 73
35 Vendor 35…………………………………………… 74
35.1 Company Profile……………………………. 74
35.2 2017- 2019 Financials…………………….. 74
35.3 COVID-19 Mitigation Activities & Products………………………………………. 75
36 Vendor 36…………………………………………… 75
36.1 Company Profile……………………………. 76
36.2 2017- 2019 Financials…………………….. 76
36.3 COVID-19 Mitigation Activities & Products………………………………………. 77
37 Vendor 37…………………………………………… 78
37.1 Company Profile……………………………. 78
37.2 2013- 2015 Financials…………………….. 78
37.3 COVID-19 Mitigation Activities & Products………………………………………. 79
[Back to top]
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 4
Download the PDF
APPENDICES…………………………………………….. 10
1 Appendix 1: Differences & Similarities Between Common Flu and Coronavirus… 10
1.1 Similarities:…………………………………… 10
1.2 Differences…………………………………… 10
2 Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel…………………………………………… 12
2.1 Introduction…………………………………… 12
2.2 Conclusions………………………………….. 13
2.3 Findings Summary…………………………. 15
2.4 Background………………………………….. 19
2.4.1 Description of the Condition……….. 19
2.4.2 Description of the Intervention…….. 20
2.4.3 How the Intervention Might Work…. 23
2.4.4 Why it Is Important To Do This Review…………………………………… 23
2.4.5 Summary………………………………… 24
3 Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection………………… 26
3.1 Introduction…………………………………… 26
3.1.1 Contingency Capacity Strategies………. 27
3.1.2 Extended Use Of Eye Protection…. 27
3.1.3 Crisis Capacity Strategies………….. 28
3.1.4 Selected Options for Reprocessing Eye Protection…………………………. 29
4 Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns……………… 29
4.1 Purpose……………………………………….. 29
4.2 Conventional Capacity Strategies……… 31
4.3 Contingency Capacity Strategies………. 31
4.4 Crisis Capacity Strategies……………….. 32
4.5 Extended Use of Isolation Gowns……… 33
4.5.1 Re-use of Cloth Isolation Gowns…. 33
4.5.2 Prioritize Gowns……………………….. 33
4.5.3 When No Gowns Are Available…… 34
5 Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks…………………….. 35
5.1 Purpose……………………………………….. 35
5.2 Conventional Capacity Strategies……… 36
5.3 Contingency Capacity Strategies………. 36
5.4 When No Facemasks Are Available, Options Include……………………………… 38
6 Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators……………… 40
7 Appendix 7: CDC Adult Vaccine Price List 43
7.1 CDC Vaccine 2020-2021 Price List……. 43
7.2 CDC Influenza Vaccine 2020-2021 Price List……………………………………………… 44
8 Appendix 8: The CDC COVID-19 Bio-Safety Guidelines………………………………………….. 46
8.1 The CDC Safety Practices for Critical Infrastructure Workers Exposed to a Person with Suspected or Confirmed COVID-19…………………………………….. 46
8.2 Use of Cloth Face Coverings……………. 46
8.3 The Emergency Medical Services Guidance……………………………………… 47
8.4 Recommendations for 911 PSAPs…….. 48
8.4.1 Modified Caller Queries……………… 48
8.5 EMS Clinicians and Medical First Responders………………………………….. 49
8.5.1 Patient assessment…………………… 49
8.6 Recommended Personal Protective Equipment……………………………………. 50
8.7 Precautions for Aerosol-Generating Procedures…………………………………… 51
8.8 EMS Transport of a PUI or Patient with Confirmed COVID-19 to a Healthcare Facility…………………………………………. 51
8.9 Documentation Of Patient Care………… 52
8.10 Cleaning EMS Transport Vehicles after Transporting a PUI or Patient with Confirmed COVID-19……………………… 53
8.11 Measures by EMS Clinicians After Caring for a PUI or Patient with Confirmed COVID-19…………………………………….. 54
8.12 EMS Employer Responsibilities………… 55
9 Appendix 9: The 2020 Global Desperation to Protect Medical Workers……………………… 56
10 Appendix 10: Disinfection Procedures for COVID-19……………………………………………. 59
10.1 Disinfection for Floor and Walls………… 59
10.2 Disinfection of Object Surfaces…………. 59
10.3 Air Disinfection………………………………. 59
10.4 Disposal of Fecal Matter and Sewage… 59
10.5 Disposal Procedures for Spills of COVID-19 Patient Blood/Fluids…………………… 60
11 Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020 61
11.1 Public Health and Social Services Emergency Fund – March 2020………… 61
11.2 For Advance Construction, Manufacture, And Purchase Of Vaccines And Therapeutic Delivery………………………. 61
11.3 Telehealth, Poison Control Centers, And The Ryan White HIV/AIDS Program….. 61
11.4 National Institutes of Health……………… 62
11.5 Substance Abuse and Mental Health Services Administration…………………… 62
11.6 Administration for Children and Families…………………………………………………… 63
11.7 Veterans Health Administration………… 63
12 Appendix 12: European Preparedness Against Emerging Epidemics……………….. 64
13 Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19……………………………………………. 66
13.1 Introduction…………………………………… 66
13.2 Diagnostic Tests……………………………. 69
13.1.1 IVD Tests………………………………… 69
13.1.2 LDT Tests……………………………….. 69
13.1.3 How are IVD Tests Regulated?…… 69
13.1.4 How are LDTs Regulated?…………. 70
13.1.5 What is CLIA and How Is It Involved in LDT Regulation?…………………… 70
13.1.6 How are IVDs Regulated by the FDA During an Emergency Such as the Outbreak of COVID-19?…………….. 71
13.1.7 How Does the Emergency Use Authority Apply to LDTs if They Are Generally Exempted from Premarket Requirements?………………………… 71
13.1.8 How Does the CDC’s COVID-19 Diagnostic Test Work?………………. 72
13.1.9 What Type of IVD is the CDC’s Test and Who May Carry it Out?………… 73
13.1.10 What Is the Role of the Commercial Manufacturer IDT in the Development and Distribution of the CDC’s Test Kit?………………………………………… 74
13.1.11 What Quality Problems Did the CDC’s Test Experience on Rollout to the State and Local Public Health Laboratories?…………………………… 74
13.1.12 What Steps did the FDA Take to Expand Testing Capacity in Response to the Problems with the CDC’s Test?……………………………………………… 75
14 Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization………………………………. 76
15 Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)……………………. 79
16 Appendix 16: Comparing Clinical COVID-19 Data by Nation……………………………………. 80
16.1 Introduction…………………………………… 80
16.2 Counting Deaths Protocols………………. 80
16.3 National Death Rates……………………… 81
16.4 National Political Factors…………………. 82
16.5 National Testing Protocols……………….. 83
16.6 Conclusions: Comparisons are Difficult. 84
17 Appendix 17: Home Healthcare IT…………. 85
17.1 Introduction…………………………………… 85
17.2 Online Bots…………………………………… 86
17.3 Home Telehealth……………………………. 86
17.4 Telemedicine Billing……………………….. 88
17.5 Commercial Insurance……………………. 88
18 Appendix 18: The Difference between PCR and Antibody Tests……………………………… 90
19 Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021……………….. 91
19.1 Introduction…………………………………… 91
19.2 Economic Effects…………………………… 93
19.3 USA…………………………………………….. 95
19.4 Europe…………………………………………. 96
19.5 The UK………………………………………… 97
19.6 Japan………………………………………….. 98
19.7 China…………………………………………… 98
19.8 The IMF……………………………………….. 98
19.9 The World Bank…………………………….. 99
19.10 Emerging Markets………………………… 100
19.11 Other Sectors………………………………. 101
20 Appendix 20: COVID-19 Tests…………….. 103
20.1 COVID-19 Tests Sensitivity and Specificity…………………………………… 103
20.2 RT-PCR tests………………………………. 104
20.3 Antibody Tests…………………………….. 105
20.4 Other Diagnostic Options………………. 108
20.5 Procurement of Test Kits and Consumables………………………………. 108
20.6 Annex A: Test Kit Options from WHO Diagnostics Consortium…………………. 109
21 Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region………………………. 118
22 Appendix 22: Abbreviations……………….. 125
23 Appendix 23: Glossary………………………. 129
24 Appendix 24: Bibliography…………………. 136
25 Research Methodology………………………. 242
25.1 Scope………………………………………… 242
25.2 Research Methodology………………….. 242
26 Disclaimer & Copyright………………………. 245
[Back to top]
